<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>01618nam a22001937a 4500</leader>
  <controlfield tag="001">D0001J000310</controlfield>
  <controlfield tag="003">DOH</controlfield>
  <controlfield tag="005">20210324134116.0</controlfield>
  <controlfield tag="008">210324b           ||||| |||| 00| 0 eng d</controlfield>
  <datafield tag="100" ind1="1" ind2=" ">
    <subfield code="a">Estalilia, Oscar Cinco </subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
    <subfield code="a">Antibodies against hepatitis C virus among blood donors at a private hospital in Cebu /</subfield>
    <subfield code="c">Oscar Cinco Estalilia</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
    <subfield code="a">Serum samples from a total of 2,852 blood donors were screened for antibodies against the Hepatitis C virus using a second generation recombinant enzyme linked immunosorbent assay in commercially prepared test kits as part of a study to determine the prevalence rate of anti-HCV among blood donors at the Cebu Doctors Hospital. 316 out of 2,852 (11.08%) blood specimens were positive for anti-HCV antibodies. 166 out of the 316 (52.53%) anti-HCV positive blood specimens had optical density absorbance cutoff values greater than 2,000 indicating a higher infectious potential. 189 out of 1,629 (11.6%) professional blood donors were anti-HCV positive. This was slightly higher when compared to 127 out of 1,223 (10.38%) anti-HCV positive volunteer blood donors. However, this was not statistically significant With the absence of other preventive measures such as active immunizations at the present time, screening for anti-HCV in all blood donors is strongly recommended to diminish the transmission of the Hepatitis C Virus through blood transfusion.</subfield>
  </datafield>
  <datafield tag="580" ind1=" " ind2=" ">
    <subfield code="a">Cebu Doctors' Proceedings, 1992 8 (2) pages 105-112</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="2">
    <subfield code="a">Hepacivirus</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="2">
    <subfield code="a">Antibodies</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="2">
    <subfield code="a">Blood Donors</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Hepatitis C virus</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="c">JA</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">3761</subfield>
    <subfield code="d">3761</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="0">0</subfield>
    <subfield code="1">0</subfield>
    <subfield code="2">nlm</subfield>
    <subfield code="4">0</subfield>
    <subfield code="7">0</subfield>
    <subfield code="a">DOHCL</subfield>
    <subfield code="b">DOHCL</subfield>
    <subfield code="c">ElectronicRes</subfield>
    <subfield code="d">2021-03-24</subfield>
    <subfield code="l">0</subfield>
    <subfield code="o">J000310</subfield>
    <subfield code="p">D0001J000310</subfield>
    <subfield code="r">2021-03-24 00:00:00</subfield>
    <subfield code="w">2021-03-24</subfield>
    <subfield code="y">JA</subfield>
  </datafield>
</record>
